- RESEARCH HIGHLIGHT
APOBEC3A drives resistance
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 22, 695 (2023)
doi: https://doi.org/10.1038/d41573-023-00122-9
References
Isozaki, H. et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature https://doi.org/10.1038/s41586-023-06303-1 (2023)